Join our Community and subscribe to our eNewsletters

Learn about Anaplastic

FACT Clinical Trial: Fosbretabulin in Anaplastic Cancer of the Thyroid

This clinical trial is no longer enrolling patients -- Tumor vascular disrupting agent combined with chemotherapy

Cancer specialists now are enrolling candidates for a clinical trial to study the safety and effectiveness of a new treatment for anaplastic thyroid cancer.

Type 1 Diabetes
Type 2 Diabetes
Osteoporosis
Hypothyroidism
Hyperthyroidism
Support Community
Clinical Trials

This information is not designed to replace a physician's independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Vertical Health & EndocrineWeb do not provide medical advice, diagnosis or treatment. Use of this website is conditional upon your acceptance of our user agreement.

Learn about Anaplastic

FACT Clinical Trial: Fosbretabulin in Anaplastic Cancer of the Thyroid

Popular Endocrinology Topics